TL;DR: Mars Petcare holds an estimated 18–22% share of the natural/premium pet food segment through brands including Royal Canin, Nutro, Crave, and Sheba, and deepened its position with the 2025 acquisition of Champion (Orijen/Acana), per Mars/globenewswire and LinkedIn reporting.
Data note. This article is a review, not breaking news: the figures and market observations below are drawn from 2025 disclosures and reporting (see Sources) and are retained here as the historical record of that period. Read it as a retrospective on what happened and why it matters, not as a claim about current-quarter results.
Context of the mars pet food share
Mars Petcare is one of two giants that define the global pet food competitive landscape. Per Mars and globenewswire reporting, the company commands an estimated 18–22% share of the natural/premium pet food segment, powered by a portfolio spanning Royal Canin, Nutro, Crave, and Sheba—and reinforced by its 2025 acquisition of Champion Petfoods (Orijen/Acana). This article maps Mars’ share, brand architecture, and strategic moves.
What Is Mars’ Pet Food Market Share?
Mars’ footprint is best expressed as an 18–22% share of natural/premium pet food (Mars/globenewswire, 2025). That is a segment share, not total-market share—Mars is especially strong where margins and growth concentrate (premium, veterinary, and biologically appropriate diets), rather than in value kibble where private label competes.
For the broader competitive frame:
- Nestlé Purina is the global #1 in cat food and holds 76.4% of cat wet (Cascadia Capital/Bloomberg Intelligence; see Nestlé Purina).
- The four CPG giants span all price tiers (Cascadia Capital/Bloomberg Intelligence; see CPG giants).
- Mars holds 64.7% of dog wet food (Cascadia Capital/Bloomberg Intelligence), underscoring its wet-food strength.
Which Brands Make Up Mars Petcare?
Mars’ portfolio is deliberately tiered:
Royal Canin
A veterinary and breed-specific science brand, top-rated among Reddit cat owners (4.2/5,) and a WSAVA-compliant staple. Royal Canin is Mars’ premium-science anchor and a direct competitor to Hill’s (Colgate), which posted +2.9% FY2025 and Q4 +4.9% (Colgate; see Hill’s).
Whiskas and Sheba
Whiskas is the global volume cat brand; Sheba is the premium wet cat line. Sheba supports Mars’ strong position in cat wet, complementing Nestlé’s 76.4% cat-wet lead.
Nutro and Crave
Nutro (natural, non-GMO-ish positioning) and Crave (high-protein, grain-free-style) target the natural/premium shopper—the exact segment where Mars claims 18–22% share.
Pedigree
The value/mass dog brand, defending Mars’ presence at the affordable end against private label.
Champion (Orijen / Acana) — acquired 2025
Mars bought a controlling stake in Champion Petfoods in 2025 (Wise Guy Reports), adding “biologically appropriate” ultra-premium lines beloved by owner forums (Orijen’s 85–90% animal content). This move pushes Mars upmarket and into raw-adjacent territory.
How Did the 2025 Champion Acquisition Change Mars’ Share?
The Champion deal is strategically significant:
- Upmarket push. Orijen/Acana sit above Royal Canin in price, letting Mars capture the fastest-growing premium and raw-curious buyers.
- Geographic balance. Champion strengthens Mars in North America and Asia, where biologically appropriate diets are trending.
- Defense against fresh. By owning premium “real food” positioning, Mars blunts the DTC fresh threat (The Farmer’s Dog ~$1.2B ARR, indexed.vc/LinkedIn; Ollie $112.65M, CB Insights/LinkedIn) without fully entering refrigerated fresh.
This follows a wave of 2025 pet M&A — Petfood Industry logged 8+ mid-size deals (; see pet M&A 2025), including General Mills’ $1.45B Whitebridge buy.
Why Is Mars Strong in Premium and Wet?
Science-led nutrition
Royal Canin’s veterinary partnerships mirror Hill’s playbook, earning vet recommendations that drive lifetime prescription and maintenance revenue.
Wet-food leadership
Mars’ 64.7% dog wet share (Cascadia Capital/Bloomberg Intelligence) reflects Whiskas/Sheba scale and the margin-rich wet category, where Nestlé leads on the cat side (76.4%).
Portfolio breadth
Unlike single-format challengers, Mars spans value (Pedigree) to ultra-premium (Orijen), letting it capture share at every price point—the same “span all tiers” strategy the four giants use (Cascadia Capital/Bloomberg Intelligence).
How Does Mars Compare to Nestlé and Hill’s?
- Nestlé Purina — larger in cat food overall; 2025 sales ~CHF 18.4B (~$22.15B), 20.6% of group (Nestlé); cat wet 76.4%.
- Mars — 18–22% natural/premium; dog wet 64.7%; adds Champion in 2025.
- Hill’s (Colgate) — vet-recommended science diets, +2.9% FY2025, Q4 +4.9%, 23% of Colgate (Colgate).
Together these three plus private label and fresh challengers define the market. For the full map, see CPG giants.
What Should Competitors and Investors Watch?
- Premium is the battleground. Mars’ 18–22% natural/premium share is where growth and margin live.
- Champion integration risk. Absorbing Orijen/Acana tests Mars’ ability to hold premium authenticity.
- Fresh deflection. Mars leans on premium dry/wet rather than refrigerated fresh (Freshpet $1.10B); watch whether that holds.
- Wet concentration. Mars’ 64.7% dog wet lead is a moat but also a concentration risk if formats shift.
What Is Mars’ Global Footprint Beyond Food?
Mars Petcare’s reach extends past the bowl:
- Veterinary services — Mars owns a large network of veterinary hospitals (Banfield, VCA, AniCura, Linnaeus) globally, giving it clinic-channel control that pure food rivals lack. This integrates food, diagnostics, and care into one owner relationship.
- Pet tech and wearables — Mars’ Whistle GPS tracker was acquired by Tractive in 2025 (LinkedIn Tractive/Brandark), showing Mars both builds and divests hardware to focus on core.
- Science and nutrition R&D — Waltham Petcare Science Institute underpins Royal Canin and Pedigree formulations, a credibility engine competitors pay to match.
This “food + clinic + science” triangle is Mars’ structural advantage over Nestlé (food-led) and Hill’s (food/vet-led but no clinic network).
How Does Mars Compete on Sustainability and R&D?
Mars leans on science-led, evidence-based nutrition to justify premium pricing—mirroring the WSAVA-compliant preference owner forums shows for Purina, Royal Canin, and Hill’s. On sustainability, Mars faces the same EU PPWR (2025/40) packaging mandate as the industry (Global PETS): recyclable packaging and PCR content, non-recyclable banned from 2030. Mars’ scale lets it absorb compliance cost better than challengers, protecting margin in its 18–22% natural/premium segment.
What Is Mars’ Innovation Pipeline?
Mars’ 2025 moves signal where it is betting:
- Champion (Orijen/Acana) — biologically appropriate, high-animal-content ultra-premium; defends against fresh/raw-curious buyers without entering refrigerated fresh directly.
- Natural/premium extension — Nutro and Crave target the 18–22% segment share Mars already claims, with clean-label and high-protein positioning.
- Veterinary depth — Royal Canin’s breed- and condition-specific lines compete head-to-head with Hill’s prescription diets (Hill’s +2.9% FY2025, Q4 +4.9%, Colgate).
Mars is essentially “out-premiuming the middle” while using clinics to lock in lifetime value—a strategy that explains its durable share even as fresh disruptors rise.
How Should Investors Read Mars’ Position?
For investors, Mars’ 18–22% natural/premium share (Mars/globenewswire) is best viewed as a quality compounder rather than a high-growth bet. The 2025 Champion acquisition is the key upside lever—if Mars integrates Orijen/Acana without diluting premium authenticity, it extends share at the highest-margin end. The main watch items: (1) whether Mars enters refrigerated fresh directly or keeps deferring to Freshpet ($1.10B); (2) vet-clinic integration economics as the US faces 243 shortage areas (AVMA/USDA); and (3) tariff exposure given 66% of pet firms tie to China supply (Global PETS). Mars’ clinic network and R&D scale make it structurally more defensible than pure-food challengers through a downturn.
Related reading
- Pet Food Market Share by CPG Giants
- Global Pet Food Market Size & Forecast
- Mars Acquires Champion (Orijen/Acana)
FAQ
What share of pet food does Mars hold?
An estimated 18–22% of natural/premium pet food (Mars/globenewswire, 2025).
Which brands are under Mars Petcare?
Royal Canin, Whiskas, Sheba, Nutro, Crave, Pedigree, and—since 2025—Orijen and Acana (Champion).
How did the 2025 Champion acquisition help Mars?
It added ultra-premium “biologically appropriate” brands, pushing Mars upmarket and into raw-curious demand.
How does Mars compare to Nestlé?
Nestlé leads cat food (76.4% cat wet, ~CHF 18.4B sales); Mars leads dog wet (64.7%) and claims 18–22% of natural/premium.
What is Mars’ wet-food strength?
Mars holds 64.7% of dog wet food (Cascadia Capital/Bloomberg Intelligence), a margin-rich, defensible position.
Sources
- Mars / globenewswire (2025) —; 18–22% natural/premium pet food share; portfolio (Royal Canin, Nutro, Crave, Sheba).
- Wise Guy Reports (2025) —; Mars acquired controlling stake in Champion (Orijen/Acana).
- Cascadia Capital / Bloomberg Intelligence (2025) —; Nestlé cat wet 76.4%, Mars dog wet 64.7%; giants span all tiers.
- Nestlé (2025) —; Purina ~CHF 18.4B, 20.6% of group, global #1 cat food.
- Colgate / Hill’s (2025) —; Hill’s +2.9% FY, Q4 +4.9%, 23% of Colgate.
- owner forums (2025) —; Royal Canin 4.2/5; Orijen 85–90% animal content.
- Indexed.vc (2025) —; The Farmer’s Dog ~$1.2B ARR.
- CB Insights (2025) —; Ollie $112.65M raised.
- Freshpet IR (2025) —; $1.10B net sales.
- Petfood Industry (2025) —; 8+ M&A deals in 2025.
- General Mills (2025) —; $1.45B Whitebridge acquisition.
